Fidelis Animal Health

Challenge

Ethiqa XR is the only FDA-indexed, extended-release buprenorphine approved for post-procedural pain management in captive rodents, ferrets, laboratory rabbits, and non-human primates. It’s a remarkable product, clinically proven and practically transformative for research facilities and veterinary professionals who work with these species. But marketing a pharmaceutical product with that level of clinical complexity requires a very specific skill: the ability to make technical content feel trustworthy and human without losing the precision that professionals require.

Solution

Open Haus developed a full suite of marketing materials for Fidelis Animal Health that balanced scientific credibility with compassion. Behind every laboratory animal is a person committed to their welfare, and that truth shaped everything we made. We designed sales aids, sell sheets, scientific comparison charts, trade show displays, and digital banner campaigns over multiple years of collaboration. The visual language we established—clean, credible, warmly clinical—helped Ethiqa XR stand apart in a category that often sacrifices design for compliance.

Result

Fidelis now has a marketing infrastructure that speaks as fluently to the research veterinarian as to the institutional procurement manager. Ethiqa XR is positioned not just as a pharmaceutical option but as the standard of care for species-specific pain management, a point reinforced whenever sales materials are presented to a decision-maker.